Akamai Technologies vs Maximus
AKAM and MMS side by side, both in miscellaneous business services. Figures are trailing twelve months unless noted, from SEC filings and end-of-day prices.
How AKAM and MMS compare
Akamai Technologies is the larger company, worth 4.0 times as much as Maximus ($13.3B against $3.3B).
On earnings, Maximus is cheaper: it trades at 9.4× trailing earnings, against 33.4× for Akamai Technologies.
Akamai Technologies grew revenue faster over the last twelve months (5.9% versus −3.3% for Maximus).
Akamai Technologies keeps more of each dollar of sales as profit, with a net margin of 9.5% compared with 7.1% at Maximus.
Maximus pays a dividend yielding 2.0%; Akamai Technologies does not pay one.
Maximus scores higher on the StockData Score (22 against 10 for Akamai Technologies), which adds up 30 checks on valuation, growth, past performance, financial health and dividends.
Key numbers
A dot marks the better figure where higher or lower is clearly better.
| Metric | AKAM | MMS |
|---|---|---|
| Size and price | ||
| Market cap | $13.3B | $3.3B |
| Share price | $92.72 | $63.72 |
| Change, 1 year | 27.0% | −25.2% |
| Change, 5 years | −13.6% | −26.1% |
| Beta (5Y) | 0.83 | 0.58 |
| Employees | 11K | 37K |
| StockData Score | ||
| Total score | 10 | 22 (better) |
| Valuation score | 2 | 6 (better) |
| Growth score | 0 | 4 (better) |
| Performance score | 3 | 6 (better) |
| Health score | 5 (better) | 4 |
| Dividend score | 0 | 2 (better) |
| Valuation | ||
| P/E | 33.4× | 9.4× (better) |
| P/S | 3.1× | 0.6× (better) |
| P/B | 2.8× | 1.9× (better) |
| EV/EBITDA | 8.4× | 7.8× (better) |
| P/FCF | 13.9× | 7.7× (better) |
| PEG | – | 0.50 |
| FCF yield | 7.2% | 13.0% (better) |
| Fair value | $96.48 | $133.26 |
| Margin of safety | 3.9% | 52.2% (better) |
| Growth | ||
| Revenue growth (TTM) | 5.9% (better) | −3.3% |
| Revenue growth, 5Y average | 5.6% | 9.4% (better) |
| Net income growth (TTM) | −3.2% | 17.3% (better) |
| EPS growth (TTM) | −1.4% | 24.7% (better) |
| EPS growth, 5Y average | −1.8% | 10.2% (better) |
| Profitability | ||
| Gross margin | 57.5% (better) | 25.6% |
| Operating margin | 10.5% | 11.0% (better) |
| Net margin | 9.5% (better) | 7.1% |
| FCF margin | 22.1% (better) | 8.3% |
| Return on equity | 8.9% | 21.1% (better) |
| Return on invested capital | 15.3% (better) | 13.2% |
| Financial health | ||
| Debt / equity | 0.00 | 0.94 (better) |
| Net debt / EBITDA | – | 2.51 |
| Interest coverage | 13.7× (better) | 6.5× |
| Current ratio | 1.64 | 2.42 (better) |
| Altman Z-score | 1.64 | 3.02 (better) |
| Piotroski F-score | 7 | 7 |
| Dividends and buybacks | ||
| Dividend yield | – | 2.0% |
| Years of dividend growth | – | 0 |
| Dividend growth, 5Y average | – | 1.4% |
| Buyback yield | 4.6% | 10.4% (better) |
| Shareholder yield | 4.6% | 12.4% (better) |
| Ownership | ||
| Held by institutions | 111% | 107% |
| Held by insiders | 2.2% | 2.2% |
| Insider net buying, 12 months | −$17.1M | −$74.8K (better) |
| Short interest, % of float | 13.7% | 6.7% |
Go deeper
- AKAM stock overview
- AKAM income statement
- AKAM valuation and score
- MMS stock overview
- MMS income statement
- MMS valuation and score
Other comparisons
For information only, not investment advice. Check the source filings before relying on any figure.